YARROW BIOSCIENCE, INC. Payments to Acquire Marketable Securities
YARROW BIOSCIENCE, INC. (YARW) reported Payments to Acquire Marketable Securities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. payments to acquire marketable securities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. payments to acquire marketable securities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. payments to acquire marketable securities for the quarter ending 2025-06-30 was $9.57M, a 39.17% increase year-over-year.
- YARROW BIOSCIENCE, INC. payments to acquire marketable securities for the quarter ending 2025-03-31 was $13.77M, a 9.23% decline year-over-year.
- YARROW BIOSCIENCE, INC. payments to acquire marketable securities for fiscal 2023 was $62.35M.
- YARROW BIOSCIENCE, INC. payments to acquire marketable securities for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $0.00 S-4/A · filed 2026-06-03 | |||
| 2025-12-31 | $30.93M S-4/A · filed 2026-06-03 | |||
| 2025-06-30 | $9.57M derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | $23.34M 10-Q · filed 2026-08-13 | $33.39M derived: sum of 3 quarters · filed 2026-08-13 | $61.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $13.77M S-4/A · filed 2026-06-03 | $23.81M derived: sum of 2 quarters · filed 2026-06-03 | $52.24M derived: sum of 3 quarters · filed 2026-06-03 | $59.12M derived: sum of 4 quarters · filed 2026-06-03 |
| 2024-12-31 | $10.04M derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | $38.47M derived: sum of 2 quarters · filed 2026-06-03 | $45.35M derived: sum of 3 quarters · filed 2026-06-03 | $60.52M S-4/A · filed 2026-06-03 |
| 2024-09-30 | $28.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $35.30M derived: sum of 2 quarters · filed 2025-08-14 | $50.47M 10-Q · filed 2024-11-07 | $112.83M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $6.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $22.05M 10-Q · filed 2025-08-14 | $84.40M derived: sum of 3 quarters · filed 2025-08-14 | $84.40M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $15.17M 10-Q · filed 2025-05-08 | $77.52M derived: sum of 2 quarters · filed 2025-05-08 | $77.52M derived: sum of 3 quarters · filed 2025-05-08 | $77.52M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $62.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $62.35M derived: sum of 2 quarters · filed 2025-03-06 | $62.35M derived: sum of 3 quarters · filed 2025-03-06 | $62.35M 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |